Finding ovarian cancer fast may not help survival

Key points
- Once a woman begins experiencing symptoms of ovarian cancer, getting diagnosed and treated quickly may not help her survive longer, according to a new study of Australian women.
- The finding is discouraging, researchers said, especially because doctors have believed that catching more cases of ovarian cancer early may help extend how long women live after diagnosis.
- Ovarian cancer kills the majority of women with the disease within 5 years.
- The results, published in the Journal of Clinical Oncology, "do not mean that women who have persistent symptoms that might be due to ovarian cancer should not seek immediate medical attention," Christina Nagle, the study's lead author from the Queensland Institute of Medical Research in Australia, told Reuters Health.
Once a woman begins experiencing symptoms of ovarian cancer, getting diagnosed and treated quickly may not help her survive longer, according to a new study of Australian women.
The finding is discouraging, researchers said, especially because doctors have believed that catching more cases of ovarian cancer early may help extend how long women live after diagnosis.
Ovarian cancer kills the majority of women with the disease within 5 years.
The results, published in the Journal of Clinical Oncology, "do not mean that women who have persistent symptoms that might be due to ovarian cancer should not seek immediate medical attention," Christina Nagle, the study's lead author from the Queensland Institute of Medical Research in Australia, told Reuters Health.
"Presenting promptly will help ensure that they are appropriately referred and can then make informed choices about their treatment," she said in an email.
Nagle and her colleagues followed almost 1,500 Australian women who were diagnosed with ovarian cancer between 2002 and 2005. The researchers interviewed the women about their symptoms and when they first went to the doctor and were diagnosed with cancer, then continued to track the participants for the next 5 years.
Most of the women had symptoms before they were diagnosed - in the others, cancer was caught at a routine check-up or during surgery for a different condition.
In women with symptoms, about 40 percent went to their doctors and were examined and diagnosed with ovarian cancer within 2 months of when the symptoms started. Within 3 months, about 60 percent of women had been diagnosed, and 6 months after symptoms began, 80 percent had been diagnosed.
Women whose cancer was picked up before symptoms started survived longer than those who had symptoms. For example, in all women with late-stage cancer, those without symptoms lived an average of 4 years after their diagnosis, compared to 3 years in women with symptoms.
But among those who did have invasive, symptomatic cancer, survival did not depend on how soon they saw their doctor.
Fifty-two percent of women who were diagnosed within 1 month of their first symptoms survived for the next 5 years, compared to 53 percent of women who took more than a year to be diagnosed.
But that doesn't necessarily mean that all efforts to get women treated fast are for naught.
Women may still get symptoms - such as daily stomach or pelvic pain, pelvic bloating or fullness, or difficulty eating - from early-stage cancer, and for them, it's possible that a quick diagnosis could improve outcomes, said M. Robyn Andersen, who studies ovarian cancer at the University of Washington in Seattle and was not involved in the current research.
Women who have new and persistent symptoms, she said, should still see their doctors.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsRisk of breast and ovarian cancer may differ by type of BRCA1, BRCA2 mutation
In a study involving more than 31,000 women with cancer-causing mutations in the BRCA1 or BRCA2 genes, researchers at The Basser Center for BRCA, the Abramson Cancer Center, and the Perelman School of Medicine at the…
8 April 2015
NewsEngineered cells could help tackle the third most common cancer in Chinese males
Researchers at the University of Birmingham believe that a new method of genetically engineering immune cells could lead to improved treatment of Nasopharyngeal carcinoma (NPC) patients. The research, published in…
11 March 2015
NewsNew therapeutic strategy discovered for ovarian cancer
Ovarian cancer is the deadliest of all cancers affecting the female reproductive system with very few effective treatments available. Prognosis is even worse among patients with certain subtypes of the disease. Now,…







